
Cannabis
Cannabis oromucosal spray slightly decreases neuropathic pain from brachial plexus injury
Pain. 2004;(3):299-306.48 adults with a brachial plexus avulsion who had experienced moderate to severe pain for at least 18 months received THC oral spray, THC+CBD oral spray, or placebo in a randomized order. The primary outcome was the average pain in the past week pain on an 11-point numeric rating scale (NRS). Secondary outcomes included sleep quality, the McGill Pain Questionnaire, Pain Disability Index, General Health Questionnaire, intoxication, and adverse effects. Pain and sleep improved significantly, but the improvements were small and likely not clinically meaningful.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.